Alarcia-Lacalle, A.; Morán-Rodríguez, M.Á.; Morata, L.; Isla, A.; Canut-Blasco, A.; Rodríguez-Gascón, A. Oritavancin Multiple Dosing for Complex Infections: A Pharmacokinetic/Pharmacodynamic Simulation Study. Pharmaceutics 2026, 18, 628. https://doi.org/10.3390/pharmaceutics18050628

AMA Style

Alarcia-Lacalle A, Morán-Rodríguez MÁ, Morata L, Isla A, Canut-Blasco A, Rodríguez-Gascón A. Oritavancin Multiple Dosing for Complex Infections: A Pharmacokinetic/Pharmacodynamic Simulation Study. Pharmaceutics. 2026; 18(5):628. https://doi.org/10.3390/pharmaceutics18050628

Chicago/Turabian Style

Alarcia-Lacalle, Ana, Miguel Ángel Morán-Rodríguez, Laura Morata, Arantxa Isla, Andrés Canut-Blasco, and Alicia Rodríguez-Gascón. 2026. "Oritavancin Multiple Dosing for Complex Infections: A Pharmacokinetic/Pharmacodynamic Simulation Study" Pharmaceutics 18, no. 5: 628. https://doi.org/10.3390/pharmaceutics18050628

APA Style

Alarcia-Lacalle, A., Morán-Rodríguez, M. Á., Morata, L., Isla, A., Canut-Blasco, A., & Rodríguez-Gascón, A. (2026). Oritavancin Multiple Dosing for Complex Infections: A Pharmacokinetic/Pharmacodynamic Simulation Study. Pharmaceutics, 18(5), 628. https://doi.org/10.3390/pharmaceutics18050628

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Article Access Statistics

For more information on the journal statistics, click here.

Multiple requests from the same IP address are counted as one view.

Article Menu

Article Versions Notes

Further Information

Guidelines

MDPI Initiatives

Follow MDPI